Liver Cancer
Copyright ©The Author(s) 2002.
World J Gastroenterol. Dec 15, 2002; 8(6): 1059-1062
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.1059
Table 2 The relationship between the expression of bax,bcl-2 and bcl-xL and clinical parameters of patients with hepatocel-lular carcinoma
nbaxbcl-2bcl-xL
Age ≤ 65100.980 ± 1.5301.960 ± 1.6783.020 ± 2.549
> 65110.882 ± 0.9620.918 ± 0.6631.900 ± 1.825
gendermale131.100 ± 1.4711.654 ± 1.5322.600 ± 2.645
female80.650 ± 0.6991.025 ± 0.8712.163 ± 1.386
gradingwell and moderate120.975 ± 1.3841.592 ± 1.5402.775 ± 2.453
poor and undifferentiated90.867 ± 1.0761.17 ± 1.0281.978 ± 1.901
tumor stageI II60.583 ± 0.4540.700 ± 0.6162.000 ± 1.616
III IV151.067 ± 1.4231.700 ± 1.4452.607 ± 2.445